1-5 of 5
Svetomir N. Markovic
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies

Eleftheria Kalogera, Wendy K. Nevala, Heidi D. Finnes, Vera J. Suman, Jill M. Schimke, Carrie A. Strand, Lisa A. Kottschade, Rachel A. Kudgus, Sarah A. Buhrow, Laura R. Becher, Liyi Geng, Gretchen E. Glaser, Megan E. Grudem, Aminah Jatoi, Carolyn M. Klampe, Amanika Kumar, Carrie L. Langstraat, Robert R. McWilliams, Andrea E. Wahner Hendrickson, S. John Weroha, Yiyi Yan, Joel M. Reid, Svetomir N. Markovic, Matthew S. Block
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (12): 2623–2635.
https://doi.org/10.1158/1078-0432.CCR-23-3196
Published: 14 June 2024
View article titled, A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies
Open the PDF for A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies in another window
Includes: Supplementary data
Journal Articles

Differential Response of Human and Mouse Dendritic Cells to VEGF Determines Interspecies Discrepancies in Tumor-Mediated Th1/Th2 Polarity Shift

Matthew S. Block, Wendy K. Nevala, Alexey A. Leontovich, Svetomir N. Markovic
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (7): 1776–1783.
https://doi.org/10.1158/1078-0432.CCR-10-2836
Published: 31 March 2011
View article titled, Differential Response of Human and Mouse Dendritic Cells to VEGF Determines Interspecies Discrepancies in Tumor-Mediated Th1/Th2 Polarity Shift
Open the PDF for Differential Response of Human and Mouse Dendritic Cells to VEGF Determines Interspecies Discrepancies in Tumor-Mediated Th1/Th2 Polarity Shift in another window
Journal Articles

Evidence of Systemic Th2-Driven Chronic Inflammation in Patients with Metastatic Melanoma

Wendy K. Nevala, Celine M. Vachon, Alexey A. Leontovich, Christopher G. Scott, Michael A. Thompson, Svetomir N. Markovic, for the Melanoma Study Group of the Mayo Clinic Cancer Center
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (6): 1931–1939.
https://doi.org/10.1158/1078-0432.CCR-08-1980
Published: 16 March 2009
View article titled, Evidence of Systemic Th2-Driven Chronic Inflammation in Patients with Metastatic Melanoma
Open the PDF for Evidence of Systemic Th2-Driven Chronic Inflammation in Patients with Metastatic Melanoma in another window
Includes: Supplementary data
Journal Articles

Early Lymphocyte Recovery Predicts Superior Survival after Autologous Hematopoietic Stem Cell Transplantation for Patients with Primary Systemic Amyloidosis

Luis F. Porrata, Morie A. Gertz, Mark R. Litzow, Martha Q. Lacy, Angela Dispenzieri, David J. Inwards, Stephen M. Ansell, Ivanna N.M. Micallef, Dennis A. Gastineau, Michele Elliott, William J. Hogan, Suzanne R. Hayman, Ayalew Tefferi, Svetomir N. Markovic
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (3): 1210–1218.
https://doi.org/10.1158/1078-0432.1210.11.3
Published: 11 February 2005
View article titled, Early Lymphocyte Recovery Predicts Superior Survival after Autologous Hematopoietic Stem Cell Transplantation for Patients with Primary Systemic Amyloidosis
Open the PDF for Early Lymphocyte Recovery Predicts Superior Survival after Autologous Hematopoietic Stem Cell Transplantation for Patients with Primary Systemic Amyloidosis in another window
Journal Articles

Aerosol Granulocyte Macrophage-Colony Stimulating Factor: A Low Toxicity, Lung-specific Biological Therapy in Patients with Lung Metastases

Peter M. Anderson, Svetomir N. Markovic, Jeffery A. Sloan, Mary Lou Clawson, Mark Wylam, Carola A. S. Arndt, William A. Smithson, Patrick Burch, Michael Gornet, Emel Rahman
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (9): 2316–2323.
Published: 01 September 1999
View article titled, Aerosol Granulocyte Macrophage-Colony Stimulating Factor: A Low Toxicity, Lung-specific Biological Therapy in Patients with Lung Metastases
Open the PDF for Aerosol Granulocyte Macrophage-Colony Stimulating Factor: A Low Toxicity, Lung-specific Biological Therapy in Patients with Lung Metastases in another window